Substrate inhibition of carnitine palmitoyltransferase by palmitoyl-CoA and activation by phospholipids and proteins

Biochim Biophys Acta. 1985 Nov 14;837(2):135-40. doi: 10.1016/0005-2760(85)90236-x.

Abstract

When carnitine palmitoyltransferase is purified it shows increasing substrate inhibition by palmitoyl-CoA as the protein content of the assay mixture is decreased. The purified enzyme is stimulated by addition of phospholipids (phosphatidylcholine, cardiolipin) and proteins (albumin, fatty acid-binding protein, lambda-globulin) to the reaction mixture. The effects of phospholipid and protein are more than additive, particularly with relatively high concentrations of palmitoyl-CoA. It is suggested that the enzyme contains hydrophobic sites which require phospholipid to prevent spurious binding of palmitoyl-CoA and which normally anchor the enzyme to the mitochondrial membrane.

MeSH terms

  • Acyl Coenzyme A / pharmacology*
  • Acyltransferases / antagonists & inhibitors*
  • Albumins / pharmacology
  • Carnitine O-Palmitoyltransferase / antagonists & inhibitors*
  • Enzyme Activation / drug effects
  • Kinetics
  • Palmitoyl Coenzyme A / pharmacology*
  • Phospholipids / pharmacology*
  • Proteins / pharmacology*

Substances

  • Acyl Coenzyme A
  • Albumins
  • Phospholipids
  • Proteins
  • Palmitoyl Coenzyme A
  • Acyltransferases
  • Carnitine O-Palmitoyltransferase